Progesterone receptor and the cell cycle modulate apoptosis in granulosa cells.
Our previous studies showed that exposure of bovine preovulatory follicles to the LH surge-induced resistance of granulosa cells, but not theca cells, to apoptosis. Here, the temporal development of resistance to apoptosis and potential roles of progesterone receptor (PR) and alterations in the cell cycle in mediating this effect were examined. Injection of cows with GnRH induced an LH surge within 2 h. Granulosa cells isolated 0, 6, and 10 h after GnRH were sensitive to Fas ligand-induced apoptosis, but cells isolated at 14 h were resistant. PR was first detectable in granulosa cells at 10 and 14 h and was not detectable in theca. Treatment of granulosa cells isolated 14 h after GnRH with the PR antagonist, RU486, induced susceptibility to apoptosis, an effect mediated by PR and not glucocorticoid receptor. After GnRH treatment, granulosa cells, but not theca cells, exited the cell cycle, expression of cyclin D2 was reduced, and p27(Kip1) was elevated. Treatment of granulosa cells isolated from small antral follicles with the G1 phase blocker, mimosine, reduced Fas ligand-induced killing, suggesting that nonproliferating cells are resistant to apoptosis. Treatment of granulosa cells isolated 14 h after GnRH with RU486 induced reentry of some cells into the cell cycle and reversed resistance to apoptosis, suggesting that cycling cells became susceptible to apoptosis. Treatment with mimosine prevented the ability of RU486 to promote susceptibility to apoptosis. In summary, the LH surge induces expression of PR by granulosa cells and withdrawal from the cell cycle, and these events promote resistance to apoptosis.
Quirk
Susan M
SM
Department of Animal Science, Morrison Hall, Cornell University, Ithaca, New York 14853, USA. smq1@cornell.edu
Cowan
Robert G
RG
Harman
Rebecca M
RM
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D002417:Cattle; D002478:Cells, Cultured; D053222:Fas Ligand Protein; D005260:Female; D005498:Follicular Phase / Q000502:physiology*; D016193:G1 Phase / Q000502:physiology; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D006107:Granulosa Cells / Q000166:cytology* / Q000378:metabolism*; D006727:Hormone Antagonists / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism; D015735:Mifepristone / Q000494:pharmacology; D011980:Receptors, Progesterone / Q000378:metabolism*; D016192:Resting Phase, Cell Cycle / Q000502:physiology
D053222:Fas Ligand Protein; D006727:Hormone Antagonists; D008562:Membrane Glycoproteins; D011980:Receptors, Progesterone; D015735:Mifepristone; D007987:Gonadotropin-Releasing Hormone; D007986:Luteinizing Hormone